Prevalence of arterial stiffness and associated factors in Thai hemodialysis patients: A multicenter cross-sectional study
CONCLUSION: There was a high prevalence of arterial stiffness among HD patients. Some modifiable factors found to be independently associated, including dialysis adequacy and glycemic control, should be further investigated to identify approaches to retard vascular stiffness.PMID:38358375 | DOI:10.5414/CN111187 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Nuanjanthip Naiyarakseree Jeerath Phannajit Wichai Naiyarakseree Thana Thongsricome Nanta Mahatanan Pagaporn Asavapujanamanee Sookruetai Lekhyananda Supat Vanichakarn Yingyos Avihingsanon Kearkiat Praditpornsilpa Somchai Eiam-Ong Paweena Susantitaphong Source Type: research
Membranous nephropathy due to malignancy: Is end stage kidney disease an irreversible final route?
Clin Nephrol. 2024 Feb 15. doi: 10.5414/CN111326. Online ahead of print.NO ABSTRACTPMID:38358376 | DOI:10.5414/CN111326 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Ana Carlota Vida Pedro Vieira Gil Silva Source Type: research
Prevalence of arterial stiffness and associated factors in Thai hemodialysis patients: A multicenter cross-sectional study
CONCLUSION: There was a high prevalence of arterial stiffness among HD patients. Some modifiable factors found to be independently associated, including dialysis adequacy and glycemic control, should be further investigated to identify approaches to retard vascular stiffness.PMID:38358375 | DOI:10.5414/CN111187 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Nuanjanthip Naiyarakseree Jeerath Phannajit Wichai Naiyarakseree Thana Thongsricome Nanta Mahatanan Pagaporn Asavapujanamanee Sookruetai Lekhyananda Supat Vanichakarn Yingyos Avihingsanon Kearkiat Praditpornsilpa Somchai Eiam-Ong Paweena Susantitaphong Source Type: research
Membranous nephropathy due to malignancy: Is end stage kidney disease an irreversible final route?
Clin Nephrol. 2024 Feb 15. doi: 10.5414/CN111326. Online ahead of print.NO ABSTRACTPMID:38358376 | DOI:10.5414/CN111326 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Ana Carlota Vida Pedro Vieira Gil Silva Source Type: research
Prevalence of arterial stiffness and associated factors in Thai hemodialysis patients: A multicenter cross-sectional study
CONCLUSION: There was a high prevalence of arterial stiffness among HD patients. Some modifiable factors found to be independently associated, including dialysis adequacy and glycemic control, should be further investigated to identify approaches to retard vascular stiffness.PMID:38358375 | DOI:10.5414/CN111187 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Nuanjanthip Naiyarakseree Jeerath Phannajit Wichai Naiyarakseree Thana Thongsricome Nanta Mahatanan Pagaporn Asavapujanamanee Sookruetai Lekhyananda Supat Vanichakarn Yingyos Avihingsanon Kearkiat Praditpornsilpa Somchai Eiam-Ong Paweena Susantitaphong Source Type: research
Membranous nephropathy due to malignancy: Is end stage kidney disease an irreversible final route?
Clin Nephrol. 2024 Feb 15. doi: 10.5414/CN111326. Online ahead of print.NO ABSTRACTPMID:38358376 | DOI:10.5414/CN111326 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Ana Carlota Vida Pedro Vieira Gil Silva Source Type: research
Prevalence of arterial stiffness and associated factors in Thai hemodialysis patients: A multicenter cross-sectional study
CONCLUSION: There was a high prevalence of arterial stiffness among HD patients. Some modifiable factors found to be independently associated, including dialysis adequacy and glycemic control, should be further investigated to identify approaches to retard vascular stiffness.PMID:38358375 | DOI:10.5414/CN111187 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Nuanjanthip Naiyarakseree Jeerath Phannajit Wichai Naiyarakseree Thana Thongsricome Nanta Mahatanan Pagaporn Asavapujanamanee Sookruetai Lekhyananda Supat Vanichakarn Yingyos Avihingsanon Kearkiat Praditpornsilpa Somchai Eiam-Ong Paweena Susantitaphong Source Type: research
Membranous nephropathy due to malignancy: Is end stage kidney disease an irreversible final route?
Clin Nephrol. 2024 Feb 15. doi: 10.5414/CN111326. Online ahead of print.NO ABSTRACTPMID:38358376 | DOI:10.5414/CN111326 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 15, 2024 Category: Urology & Nephrology Authors: Ana Carlota Vida Pedro Vieira Gil Silva Source Type: research
Effect of glutathione-assisted continuous renal replacement therapy in sepsis patients with acute renal injury
This study explored the effect of glutathione assisted continuous renal replacement therapy (CRRT) on peripheral blood receptors in sepsis patients with acute kidney injury. A total of 196 sepsis patients with acute kidney injury were recruited to perform a retrospective cohort study, 98 patients treated with glutathione combined with CRRT were included as the combination group, and then 98 patients treated with CRRT alone were included as the control group during the same period. The outcome was changes in the levels of blood urea nitrogen (BUN), serum creatinine (Scr), peripheral blood receptors, acute physiology and chr...
Source: Clinical Nephrology - February 8, 2024 Category: Urology & Nephrology Authors: Huaqing Liu Yinghui Tian Cuilan Liu Dawei Wang Huijuan Wang Source Type: research
Comparison of the hemoglobin variability in non-chronic kidney disease or end-stage renal disease participants and patients with CKD and ESRD
CONCLUSION: Hb variability is a common phenomenon in all groups independently of the method used for assessment and even without EPO therapy. The target range is difficult to achieve for HD patients and should be reconsidered in the future to avoid unsettling both the patients and the staff.PMID:38329918 | DOI:10.5414/CN111225 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 8, 2024 Category: Urology & Nephrology Authors: Carlos Plappert Hans-Joachim M üller Marion Haubitz Ralf H öcker Heike Wei ßer Peter Ben öhr Source Type: research
Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report
We report on a 53-year-old Japanese man diagnosed with gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder (B-PTLD) after endoscopy for gastric discomfort 28 months after the patient underwent renal transplantation in Ethiopia. Serum Epstein-Barr virus (EBV) tests were negative before transplantation, but the tumor cells collected from a gastric biopsy showed positive EBV-encoded small RNAs (EBER) at B-PTLD onset. Intensive treatment started with R(rituximab)-CHOP therapy and continued with DA-EPOCH-R therapy has been effective, and relapse has not yet occurred. Burkitt lymphoma has a poor prognosis,...
Source: Clinical Nephrology - February 8, 2024 Category: Urology & Nephrology Authors: Yusuke Yoshimura Tatsuya Suwabe Arisa Fujiki Daisuke Kaji Yuki Asano-Mori Yuki Oba Hiroki Mizuno Masayuki Yamanouchi Kiho Tanaka Eiko Hasegawa Katsuyuki Miki Takayoshi Yokoyama Yuki Namamura Yasuo Ishii Satoshi Yamashita Kei Kono Keiichi Kinowaki Yutaka T Source Type: research
Intraperitoneal vancomycin plus levofloxacin for the treatment of peritoneal dialysis-related peritonitis in patients with no response to cefazolin plus ceftazidime
CONCLUSION: Vancomycin plus levofloxacin may be effective if patients are not responsive to cefazolin plus ceftazidime.PMID:38329920 | DOI:10.5414/CN111186 (Source: Clinical Nephrology)
Source: Clinical Nephrology - February 8, 2024 Category: Urology & Nephrology Authors: Jiafan Zhou Yajuan Huang Xing Zhang Liping Xiong Rui Zhang Hongrui Shi Source Type: research
Efficacy and safety of difelikefalin in the treatment of hemodialysis patients with pruritus: A meta-analysis and systematic review
CONCLUSION: Although difelikefalin can improve itching symptoms in HD patients, it can also increase adverse reactions based on the current literature. Therefore, more studies are needed to further explore the safety and efficacy of difelikefalin treatment.PMID:38294219 | DOI:10.5414/CN111169 (Source: Clinical Nephrology)
Source: Clinical Nephrology - January 31, 2024 Category: Urology & Nephrology Authors: Guifang Xue Huaihong Yuan Dandan Fan Yujie Yang Chunyan Ma Jing Liu Ruoxi Liao Source Type: research
Recurrence of crescentic IgA nephropathy 3 years after successful treatment
Clin Nephrol. 2024 Jan 31. doi: 10.5414/CN111224. Online ahead of print.NO ABSTRACTPMID:38294220 | DOI:10.5414/CN111224 (Source: Clinical Nephrology)
Source: Clinical Nephrology - January 31, 2024 Category: Urology & Nephrology Authors: Hiroshi Yamashita Masahiro Okabe Hiroyuki Ueda Yoichi Miyazaki Takashi Yokoo Source Type: research
Incidence trends of kidney cancer in China from 1990 to 2019: A joinpoint and age-period-cohort analysis
CONCLUSION: The incidence of kidney cancer is increasing rapidly in China. The kidney cancer burden will rise in the next decades due to population aging, environmental pollution, occupation, food safety, and so on. Results of this study suggest that more etiological studies should be performed to identify the driving factors for kidney cancer trends, and appropriate preventive measures should be implemented for the age-, period-, and cohort-related factors in the population.PMID:38214174 | DOI:10.5414/CN111280 (Source: Clinical Nephrology)
Source: Clinical Nephrology - January 12, 2024 Category: Urology & Nephrology Authors: Liling Zhang Yuansheng Li Ningjun Ren Tingting Zhu Dongmei Zhang Saotao Ou Defeng Yin Source Type: research
